Business
Microbot Medical®’s LIBERTY® Endovascular Robotic System Continues to Expand Market Visibility; Being Featured at an Industry Leading Innovation Conference
Global Robotic Leaders Convene to Discuss & Highlight Surgical Advancements of the Next Decade with a Special Focus on the Endovascular SpaceHINGHAM, Mass., Feb. 19, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY® Endovascular Robotic System, announced that Harel Gadot, CEO, President and Chairman, will be a featured panelist at The Surgical Disruptive Technology Summit, which is part of SAGES NBT Innovation Weekend, taking plac
About this update from Microbot Medical Inc.
[{"type":"image","alt":"Microbot Medical Inc.","displaySize":"","headline":null,"caption":"Microbot Medical Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":127,"url":"https://media.zenfs.com/en/globenewswire.com/9626a8786202041757b3030226d69d16"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/8sc4mubv858DmIYRrwJwfA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE3ODtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/9626a8786202041757b3030226d69d16","width":300,"height":127}},"lazy":false},{"type":"text","content":"Global Robotic Leaders Convene to Discuss & Highlight Surgical Advancements of the Next Decade with a Special Focus on the Endovascular Space","length":145,"tagName":"p"},{"type":"text","content":"HINGHAM, Mass., Feb. 19, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY® Endovascular Robotic System, announced that Harel Gadot, CEO, President and Chairman, will be a featured panelist at The Surgical Disruptive Technology Summit, which is part of SAGES NBT Innovation Weekend, taking place February 19-21 in Houston, TX. SAGES’s mission is to innovate, educate and collaborate to improve patient care, and the SAGES NBT Innovation Weekend serves as an open forum for dialogue between industry and providers on innovations in surgical technology and surgical practice.","length":638,"tagName":"p"},{"type":"text","content":"Industry thought leaders, including robotic pioneers, will discuss advancing technologies with a focus on minimally invasive and less invasive interventions. A dedicated panel, titled Endovascular Therapeutics: AI and Robotics, will provide Mr. Gadot with a platform to highlight the unique features of the LIBERTY System, allowing the Company to establish a new category of surgical robotics. The Company believes that the growing confidence in AI and robotic innovations in endovascular procedures can support the accelerated adoption of LIBERTY. These innovations include remote interventions, precision navigation, and catheter-based robotics designed to enhance access, safety, and clinical outcomes across vascular care.","length":726,"tagName":"p"},{"type":"text","content":"“We believe that the continued emergence of the LIBERTY System, together with the expanding range of procedures performed to date, is redefining how endovascul...